Westminster Health Forum

The future of personalised and genomic medicine

Morning, Thursday, 14th December 2017

Central London

THIS EVENT IS CPD CERTIFIED



With NHS England setting out plans to develop a genomic medicine service for the NHS as part of the Next steps for the Five Year Forward View, delegates at this seminar will discuss the next steps for scaling up personalised medicine, following findings from the 100,000 Genomes Project.


Attendees will assess the challenges for funding the development of genomic medicine and realising potential cost savings through improved diagnoses and prevention, key issues in the use of genomic data to achieve better health outcomes - as well as progress made by Health Education England’s Genomics Education Programme in engaging with health professionals and supporting the development of new skills.


Further sessions will focus on the potential impact of a genomic medicine service for people with rare diseases, following NHS England’s commitment to publish an implementation plan for the UK strategy, priorities for enhancing the NHS’ diagnostics capacity and the next steps for involving patients and the public in the development of personalised medicine.



Guest of Honour

Professor Sue Hill

Chief Scientific Officer, NHS England

Guest of Honour

Professor Sue Hill

Chief Scientific Officer, NHS England

Keynote Speakers

Professor Sir Munir Pirmohamed

NHS Chair of Pharmacogenetics and Associate Pro-Vice Chancellor for Clinical Research, University of Liverpool and Executive Director, Liverpool Health Partners

Dr Paul Brennan

Clinical Director, Northern Genetics Service and Clinical Programme Lead, North East and North Cumbria NHS Genomic Medicine Centre

Chair

Rt Hon the Lord Warner

former Parliamentary Under-Secretary and Minister of State, Department of Health

Speakers

Dr Mark Kroese

Director, PHG Foundation

Dr Jayne Spink

Chief Executive Officer, Genetic Alliance UK

Dr Virginia Acha

Executive Director, Research, Medical and Innovation, ABPI

Dr Krishna Prasad

Group Manager, MHRA

Doris-Ann Williams

Chief Executive, British In Vitro Diagnostics Association